Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Suriname is experiencing significant growth due to changing customer preferences and local special circumstances. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Suriname are shifting towards natural and herbal remedies. Consumers are becoming more health-conscious and are seeking alternative treatments for digestive and intestinal issues. This trend is in line with the global market, where there is a growing demand for natural and organic products. Trends in the market include the increasing availability of digestive and intestinal remedies in pharmacies across Suriname. Pharmacies are expanding their product offerings to meet the rising demand for these remedies. Additionally, there is a growing awareness among consumers about the importance of maintaining a healthy digestive system, leading to increased sales of digestive and intestinal remedies. Local special circumstances in Suriname also contribute to the development of the Digestive & Intestinal Remedies (Pharmacies) market. Suriname has a diverse population with different cultural backgrounds, and traditional herbal remedies have long been used to treat digestive and intestinal issues. This cultural influence has led to a preference for natural remedies, driving the demand for herbal digestive and intestinal products in pharmacies. Underlying macroeconomic factors, such as the overall economic growth in Suriname, also play a role in the development of the market. As the economy improves, consumers have more disposable income to spend on healthcare products, including digestive and intestinal remedies. Additionally, the government's focus on improving healthcare infrastructure and access to medication has further fueled the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Suriname is growing due to changing customer preferences towards natural remedies, increasing availability of these products in pharmacies, local cultural influences, and the overall economic growth in the country.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
